Effect of Silymarin as Add on Therapy on Oxidative Stress, Pulmonary Function and Quality of Life in Stable COPD Patients.

NAEnrolling by invitationINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 20, 2025

Primary Completion Date

November 15, 2025

Study Completion Date

December 31, 2025

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Interventions

DIETARY_SUPPLEMENT

Silymarin

Participants received Silymarin 140 mg capsule orally thrice daily for 12 weeks

DIETARY_SUPPLEMENT

Placebo

Participants received Silymarin placebo capsule thrice daily for 12 weeks

Trial Locations (1)

BSMMU, Dhaka

All Listed Sponsors

lead

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

OTHER